SCHEMBL8315484

SCHEMBL8315484

Sc1cccnc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29191177 0.78 NPC1 (0.42)
SCHEMBL41049 0.72
SCHEMBL29581302 0.72
SCHEMBL687504 0.72 PSMD14 (0.52)
SCHEMBL27892006 0.72 LMNA (0.48)
SCHEMBL29361780 0.72
SCHEMBL2697704 0.72
Chloroform SCHEMBL27952669 0.72 LMNA (0.43)
SCHEMBL29398460 0.70
SCHEMBL31147201 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119264533-A Low-temperature-resistant rare earth butadiene rubber and preparation method thereof 山东产研中科高端化工产业技术研究院有限公司 2025-01-07 CN claimed
CN-119264533-A Low-temperature-resistant rare earth butadiene rubber and preparation method thereof 山东产研中科高端化工产业技术研究院有限公司 2025-01-07 CN disclosed
EP-3753941-B1 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO LTD (CN) 2024-05-01 EP disclosed
US-20230234958-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF D. E. SHAW RESEARCH, LLC 2023-07-27 US disclosed
US-11498930-B2 Pyrimidine-fused cyclic compound, preparation method therefor and application thereof Blueray Therapeutics (Shanghai) Co., Ltd (CN) 2022-11-15 US disclosed
US-11498930-B2 Pyrimidine-fused cyclic compound, preparation method therefor and application thereof Blueray Therapeutics (Shanghai) Co., Ltd (CN) 2022-11-15 US disclosed
WO-2022135430-A1 HETEROARYL COMPOUNDS, PREPARATION METHODS AND USES THEREOF InventisBio Co., Ltd. (CN) 2022-06-30 WO disclosed
US-20210053989-A1 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2021-02-25 US disclosed
US-20210053989-A1 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF SHANGHAI BLUERAY BIOPHARMA CO., LTD. (CN) 2021-02-25 US disclosed
EP-3753941-A1 PYRIMIDINE-FUSED CYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Shanghai Blueray Biopharma Co., Ltd. (CN) 2020-12-23 EP disclosed
WO-2016203406-A1 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2016-12-22 WO disclosed
WO-2016203405-A1 COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2016-12-22 WO disclosed
US-9249160-B2 Orexin receptor antagonists HEPTARES THERAPEUTICS LIMITED (GB) 2016-02-02 US disclosed
WO-2015107494-A1 1 -(TRIAZIN-3-YI_/PYRIDAZIN-3-YL)-PIPER(-AZINE)IDINE DERIVATIVES AND COMPOSITIONS THEREOF FOR INHIBITING THE ACTIVITY OF SHP2 NOVARTIS AG (CH) 2015-07-23 WO disclosed
US-20150126498-A1 OREXIN RECEPTOR ANTAGONISTS NXERA PHARMA UK LIMITED (GB) 2015-05-07 US disclosed
EP-0611757-B1 Process for the preparation of azaphenothiazines ASTA MEDICA AG (DE) 1999-01-20 EP disclosed
US-5539107-A REACTION OF CHLOROPYRIDINE AND CHLOROQUINOLINES WITH MERCAPTOANILINES OR BIS/O-AMINOPHENYL DISULFIDE ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1996-07-23 US disclosed
US-5446148-A Chemical intermediates for making antitussive agent, antihistamines and antipsychotic agent; efficiency, by-product inhibition ASTA MEDICA AKTIENGESELLSCHAFT (DE) 1995-08-29 US disclosed
EP-0611757-A1 Process for the preparation of azaphenothiazines ASTA Medica Aktiengesellschaft (DE) 1994-08-24 EP disclosed
US-4148899-A BACTERICIDES, FUNGICIDES THE DOW CHEMICAL COMPANY (US) 1979-04-10 US disclosed